Join
Live feed
·
INSIDERFilingvia Quantisnow
Neumora Therapeutics Inc. logo

Head of R&D Lenz Robert A. sold $208,110 worth of shares (13,823 units at $15.06), decreasing direct ownership by 4% to 314,706 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
NMRA· Neumora Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NMRA (Neumora Therapeutics Inc.) and more on Quantisnow.